Unlike other cytokines, interleukin-22 (IL-22), a small cytokine mainly produced by Th1, Th17, Th22 and ILC3 cells, has been shown to alleviate metabolic disorders in mice and protect pancreatic islet properties beyond its immunological functions [21,22]. Here, IL22 is linked to metabolic disease.